Data Availability
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
References
Saba JD, Keller N, Wang JY, et al. Genotype/phenotype interactions and first steps toward targeted therapy for sphingosine phosphate lyase insufficiency syndrome. Cell Biochem Biophys. 2021;79:547–59. https://doi.org/10.1007/s12013-021-01013-9.
Prasad R, Hadjidemetriou I, Maharaj A, et al. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. J Clin Invest. 2017;127(3):942–953. https://doi.org/10.1172/JCI90171
Lovric S, Goncalves S, Gee HY, et al. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest. 2017;127(3):912–28. https://doi.org/10.1172/JCI89626.
Zamora-Pineda J, Kumar A, Suh JH, Zhang M, Saba JD. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213(12):2773–91. https://doi.org/10.1084/jem.20160287.
Jyonouchi S, Jongco AM, Puck J, Sullivan KE. Immunodeficiencies associated with abnormal newborn screening for T cell and B cell lymphopenia. J Clin Immunol. 2017;37(4):363–74. https://doi.org/10.1007/s10875-017-0388-4.
Vogel P, Donoviel MS, Read R, et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One. 2009;4(1):e4112. https://doi.org/10.1371/journal.pone.00041126.
Acknowledgements
We thank Professor Sophie Hambleton and her professional team at Newcastle University for their assistance with genetic analyses.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
The first draft of the manuscript was written by PT, and all authors commented on previous versions of the manuscript. The data collection was performed by MJ. KS and MJ assisted in writing the manuscript. The authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Informed consent for publication was obtained from the parents.
Conflict of Interest
The authors declare they have no conflict of interest.
Consortia Authorship
Paulina Tran DO; Mahnaz Jamee, MD; Daniella Levy-Erez MD (Division of Nephrology, Children’s Hospital of Philadelphia; Schneider Children’s Medical Center, Institute of Nephrology; Perelman School of Medicine at the Univeristy of Pennsylvania); Zahra Pournasiri, MD; Zahra Chavoshzadeh, MD; Kathleen E. Sullivan MD PhD.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tran, P., Jamee, M., Pournasiri, Z. et al. SGPL1 Deficiency: Nephrotic Syndrome with Lymphopenia. J Clin Immunol 43, 72–75 (2023). https://doi.org/10.1007/s10875-022-01348-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-022-01348-9